Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Zydus Lifesciences bags USFDA okay for arthritis drug Celecoxib

Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban

Ruchika Sharma14 April 2025 11:30 AM IST

Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...

US tariffs on pharma sector would be counterproductive for Americans, says Wockhardt Chairman

Ruchika Sharma13 April 2025 3:15 PM IST

Wockhardt Chairman Habib Khorakiwala said that U.S. tariffs on pharmaceutical products would ultimately be counterproductive for Americans.The U.S....

Setback To Novartis: CDSCO Panel Rejects Lanalumab Phase III Trial Design Over Study Flaws

Novartis plans to invest USD 23 billion over next 5 years in US based infrastructure

Ruchika Sharma13 April 2025 12:30 PM IST

East Hanover: Novartis, a global medicines company, has announced a planned USD 23 billion investment over 5 years in US-based infrastructure,...

CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten Study

Pomalyst monopoly case: Bristol Myers wins dismissal of lawsuit

Ruchika Sharma13 April 2025 11:00 AM IST

A federal judge in New York has dismissed a proposed class action against pharmaceutical giant Bristol Myers Squibb, which accused the company of...

Morepen Labs plans to employ over 1000 professionals

Ruchika Sharma12 April 2025 1:52 PM IST

Gurugram: Morepen Laboratories Ltd. has announced the addition of more than 1,000 professionals to its salesforce over the next three years,...

Raid at quack clinic in Telangana, drugs including Amoxycillin seized

Ruchika Sharma12 April 2025 12:33 PM IST

Telangana: Drugs Control Administration, Telangana raided a quack's clinic in Medaram Village, Tadvai Mandal, Mulugu District and seized drugs...

Zydus Lifesciences receives tentative approval from USFDA for Chronic lymphocytic leukaemia drug Ibrutinib

Zydus Lifesciences bags USFDA nod for Duchenne muscular dystrophy drug Jaythari

Ruchika Sharma12 April 2025 11:30 AM IST

Ahmedabad: Pharma major, Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA)...

Granules India arm gets 1 USFDA observation for Hyderabad facility

Aurobindo Pharma arm gets 11 USFDA observations for Raleigh Plant

Ruchika Sharma11 April 2025 5:46 PM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has issued 11 observations after an...

USFDA plans to phase out animal testing requirement for monoclonal antibodies, other drugs

Ruchika Sharma11 April 2025 4:08 PM IST

In a significant move toward modernizing drug development, the U.S. Food and Drug Administration (USFDA) has announced plans to phase out its...

Granules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals

Granules India successfully closes acquisition of Swiss based CDMO Senn Chemicals

Ruchika Sharma11 April 2025 3:05 PM IST

Hyderabad: Granules India Limited has announced the successful closing of the acquisition of Senn Chemicals AG, a Swiss based Contract...

Alembic Pharma Carbamazepine Extended Release

Biocon arm secures USFDA approval for Everolimus Tablets for prophylaxis of organ rejection in adult patients

Ruchika Sharma11 April 2025 12:30 PM IST

Bangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval...

Cipla Bommasandra facility gets VAI classification from USFDA

Cipla gets USFDA nod for Paclitaxel Protein bound Particles for Injectable Suspension

Ruchika Sharma11 April 2025 11:30 AM IST

Mumbai: Cipla has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) for the ...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok